Những cân nhắc an toàn cho Nhân viên y tế tham gia Phẫu thuật cắt bỏ tế bào và Hóa trị liệu trong thời kỳ phẫu thuật

Elias D, Goéré D, Dumont F, Honoré C, Dartigues P, Stoclin A, Malka D, Boige V, Ducreux M (2014) Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases. Eur J Cancer 50(2):332–340 Chua TC, Moran BJ, Sugarbaker PH, et al. (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30:2449–2456[11] Yan TD, Deraco M, Baratti D, et al. (2009) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 27:6237–6242 Elias D, Gilly F, Boutitie F, et al. (2010) Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 28:63–68 Glehen O, Gilly FN, Arvieux C, et al. (2010) Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 17(9):2370–2377 Mulier S, Claes JP, Dierieck V, Amiel JO, Pahaut JP, Marcelis L, Bastin F (2012) Survival Benefit of Adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the Different Time-points of Treatment of Ovarian Cancer: Review of Evidence. Curr Pharm Des 18:3793–3803 Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221(1):29–42 Van der Speeten K, Stuart OA, Sugarbaker PH (2009) Pharmacokinetics and pharmacodynamics of perioperative cancer chemotherapy in peritoneal surface malignancy. Cancer J 15:216–224 Cushing H (1928) Electrosurgery as an aid to the removal of intracranial tumors. Surg Gynaecol Obstet 47:751–784 Sugarbaker PH (1994) Dissection by electrocautery with a ball tip. J Surg Oncol 56:246–248 Sugarbaker PH (1996) Laser-mode electrosurgery. Cancer Treat Res 82:375–385 Sudhindra TV, Joseph A, Hacking CJ, Haray PN (2000) Are surgeons aware of the dangers of diathermy? Ann R Coll Surg Engl 82:31–32 Spearman J, Tsavellas G, Nichols P (2007) Current Attitudes and Practices Towards Diathermy Smoke. Ann R Coll Surg Engl 89(2):162–165 Ulmer BC (1997) Air Quality in the operating room. Surg Serv Manage 3(3):18–21 Nicola JH, Nicola EM, Vieira R, Braile DM, Tanabe MM, Baldin DH (2002) Speed of particles ejected from animal skin by CO2 laser pulses, measured by laser Doppler velocimetry. Phys Med Biol 47(5):847–856 Taravella MJ, Viego J, Luiszer F, et al. (2001) Respirable particles in the excimer laser plume. J Cataract Refract Surg 27(4):604–607 Dykes CN (1999) Is it safe to allow smoke in our operating room? Today’s Surg Nurse 21(2):15–21 Ulmer BC. The hazards of surgical smoke AORN J, Volume 87, Issue 4, 721–738 Peters A, Wichmann HE, Tuch T, Heinrich J, Heyder J (1997) Respiratory Effects Are Associated with the Number of Ultrafine Particles. Am J Respir Crit Care Med 155:1376–1383 Alp E, Bijl D, Bleichrodt RP, Hansson B, Voss A (2006) Surgical smoke and infection control. J Hosp Infect 62:1–5 Some Non-heterocyclic Polycyclic Aromatic Hydrocarbons and Some Related Exposures. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 92. World Health Organization International Agency For Research On Cancer. Lyon, France: 2010 Boffetta P, Jourenkova N, Gustavsson P (1997) Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control 8:444–472 Sjaastad AK, Bramming Jørgensen R, Svendsen K (2010) Exposure to polycyclic aromatic hydrocarbons (PAHs), mutagenic aldehydes and particulate matter during pan frying of beefsteak. Occup Environ Health 67:228–232 Zhu L, Wang J (2003) Sources and patterns of polycyclic aromatic hydrocarbons pollution in kitchen air. China Chemosphere 50:611–618 Tuntawiroon J, Mahidol C, Navasumrit P, Autrup H, Ruchirawat M (2007) Increased health risk in Bangkok children exposed to polycyclic aromatic hydrocarbons from traffic-related sources. Carcinogenesis 28:816–822 Liu YN, Tao S, Dou H, Zhang TW, Zhang XL, Dawson R (2007) Exposure of traffic police to Polycyclic aromatic hydrocarbons in Beijing. China Chemosphere 66:1922–1928 Bari A, Baumbach G, Kuch B, Scheffknecht G (2010) Particle-phase concentrations of polycyclic aromatic hydrocarbons in ambient air of rural residential areas in southern Germany. Air Qual Atmos Health 3:103–116 Hoffmann D, Hoffmann I, El-Bayoumy K (2001) The Less Harmful Cigarette: A Controversial Issue. A Tribute to Ernst L Wynder. Chem Res Toxicol 14:767–790 Tomita Y, Mihashi S, Nagata K, Ueda S, Fujiki M, Hirano M, et al. (1981) Mutagenicity of smoke condensates induced by CO2-laser irradiation and electrocauterzation. Mutat Res 89:145–149 Burstyn I, Boffetta P, Heederik D, Partanen T, Kromhout H, Svane O, et al. (2003) Mortality from Obstructive Lung Diseases and Exposure to Polycyclic Aromatic Hydrocarbons among Asphalt Workers. Am J Epidemiol 158:468–478 Burstyn I, Kromhout H, Partanen T, Svane O, Langård S, Ahrens W, et al. (2005) Polycyclic Aromatic Hydrocarbons and Fatal Ischemic Heart Disease. Epidemiology 16:744–750 Brace MD, Stevens E, Taylor SM, et al. (2014) The air that we breathe: assessment of laser and electrosurgical dissection devices on operating theater air quality. J Otolaryngol Head Neck Surg 43(1):39 Pyrolysis. In: Webster’s College Dictionary. New York, NY: Random House; 2001:1078 Capizzi PJ, Clay RP, Battey MJ (1998) Microbiologic activity in laser resurfacing plume and debris. Lasers Surg Med 23(3):172–174 Garden JM, O’Banion K, Bakus AD, Olson C (2002) Viral disease transmitted by laser-generated plume (aerosol). Arch Dermatol 138(10):1303–1307 Baggish MS, Baltoyannis P, Sze E (1988) Protection of the rat lung from the harmful effects of laser smoke. Lasers Surg Med 8(3):248–253 Mowbray N, Ansell J, Warren N, Wall P, Torkington J (2013) Is surgical smoke harmful to theater staff? A systematic review. Surg Endosc 27(9):3100–3107. doi:10.1007/s00464-013-2940-5 Barrett WL, Garber SM (2003) Surgical smoke: a review of the literature. Is this just a lot of hot air? Surg Endosc 17(6):979–987. doi:10.1007/s00464-002-8584-5 Bigony L (2007) Risks associated with exposure to surgical smoke plume: a review of the literature. AORN J 86(6):1013–1020 Esquivel J (2009) Technology of Hyperthermic Intraperitoneal Chemotherapy in the United States, Europe, China, Japan, and Korea. Cancer J 15:249–254 Glehen O, Cotte E, Kusamura S, Deraco M, Baratti D, Passot G, et al. (2008) Hyperthermic Intraperitoneal Chemotherapy: Nomenclature and Modalities of Perfusion. J Surg Oncol 98:242–246 Sugarbaker PH, Jaquet P, Stephens AD, Stuart OA, Averbach AM (1996) Comparison of covered versus closed technique for heated intraoperative intraperitoneal chemotherapy for peritoneal carcinomatosis from gastrointestinal cancer. In: Abe O, Inokuch K, Takasaki K (eds) The XXX World Congress of the International Colleague of Surgeons. Monduzzi Editore, Bologna, pp. 389–393 Sugarbaker PH. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol. 1999; 43(Suppl): S15-S25. Ortega-Deballon P, Facy O, Jambet S, Magnin G, Cotte E, Beltramo JL, et al. (2010) Which Method to Deliver Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin? An Experimental Comparison of Open and Closed Techniques. Ann Surg Oncol 17:1957–1963 Gonzalez-Moreno S, Gonzalez-Bayon L, Ortega-Perez G (2010) Hyperthermic intraperitoneal chemotherapy: Rationale and technique. World J Gastrointest Oncol 2(2):68–75 Gonzalez-Bayon L, Gonzalez-Moreno S, Ortega-Perez G (2006) Safety considerations for operating room personnel during hyperthermic intraoperative intraperitoneal chemotherapy perfusion. Eur J Surg Oncol 32:619–624 Connor TH, Shults M, Fraser MP (2000) Determination of the vaporization of solutions of mutagenic antineoplastic agents at 23 and 37 °C using a desiccator technique. Mutat Res 410(1):85–92 Stuart OA, Stephens AD, Welch L, Sugarbaker PH (2002) Safety monitoring of the coliseum technique for heated intraoperative intraperitoneal chemotherapy with mitomycin C. Ann Surg Oncol 9(2):186–191 Schmid K, Boettcher MI, Pelz JO, Meyer T, Korinth G, Angerer J, Drexler H (2006) Investigations on safety of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with Mitomycin C. Eur J Surg Oncol 32:1222–1225 Villa A, Balkhi S, Aboura R, Sageot H, Hasni-Pichard H, Pocard M, Elias D, Joly N, Payen D, Blot F, Poupon J, Garnier R (2015) Evaluation of oxaliplatin exposure of healthcare workers during heated intraperitoneal perioperative chemotherapy (HIPEC). Ind Health 53:28–37 Schierl R, Novotna J, Piso P, Böhlandt A, Nowak D (2012) Low surface contamination by cis/oxaliplatin during hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Surg Oncol 38:88–94 Guerbet M, Goullé JP, Lubrano J (2007) Evaluation of the risk of contamination of surgical personnel by vaporization of oxaliplatin during the intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Surg Oncol 33(5):623–626 Konate A, Poupon J, Villa A, Garnier R, Hasni-Pichard H, Mezzaroba D, Fernandez G, Pocard M (2011) Evaluation of environmental contamination by platinum and exposure risks for healthcare workers during a heated intraperitoneal perioperative chemotherapy (HIPEC) procedure. J Surg Oncol 103:6–9 Näslund Andréasson S, Anundi H, Thorén SB, Ehrsson H, Mahteme H (2010) Is Platinum Present in Blood and Urine from Treatment Givers during Hyperthermic Intraperitoneal Chemotherapy? J Oncol 2010:649,719 Valanis BG, Vollmer WM, Labuhn KT, Glass AG (1993) Association of antineoplastic drug handling with acute adverse effects in pharmacy personnel. Am J Hosp Pharm 50:455–462 Valanis B, Vollmer WM, Steele P (1999) Occupational exposure to antineoplastic agents: self-reported miscarriages and stillbirths among nurses and pharmacists. J Occup Environ Med 41:632–638 Dranitsaris G, Johnson M, Poirier S, et al. (2005) Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature. J Oncol Pharm Pract 11:69–78 Martin S Chemotherapy handling and effects among nurses and their offspring. Paper presented at: the Oncology Nursing Society 30th Annual Congress; April 28–May 1, 2005; Orlando, Fla. Abstract 13 International Agency for Research on Cancer. IARC Monographs Database on Carcinogenic Risks to Humans. Available at: http://monographs.iarc.fr/. Accessed January 14, 2015 Gabriele P, Airoldi M, Succo G, Brando V, Ruo Redda MG (1993) Undifferentiated nasopharyngeal-type carcinoma in a nurse handling cytostatic agents. Oral Oncol, Eur J Cancer 29B:153 Letter Levin LI, Holly EA, Seward JP (1993) Bladder cancer in a 39-year-old female pharmacist. J Natl Cancer Inst 85:1089–1090 Gunnarsdottir HK, Aspelund T, Karlsson T, Rafnsson V (1997) Occupational risk factors for breast cancer among nurses. Int J Occup Environ Health 3:254–258 Ratner PA, Spinelli JJ, Beking K, Lorenzi M, Chow Y, Teschke K, Le ND, Gallagher RP, Dimich-Ward H (2010) Cancer incidence and adverse pregnancy outcome in registered nurses potentially exposed to antineoplastic drugs. BMC Nurs 9:15 Shen C-C, Hu Y-W, Hu L-Y, et al. (2013) The risk of cancer among taiwanese female registered nurses: a nationwide retrospective study. PLoS One 8(7):e68420. doi:10.1371/journal.pone.0068420 NIOSH Hazard Controls. Control of smoke from laser/electrical surgical procedures. US Department of Health and Human Services. National Institute of Occupational Safety and Health Sept 1996. Available at http://www.cdc.gov/niosh/docs/hazardcontrol/hc11.html AORN. Recommended practices for a safe environment of care. 2010 Perioperative standards and recommended practices. 2009; 217–240. American Society of Heating, Refrigerating and Air-Conditioning Engineers, Inc. Ventilation of health care facilities. ANSI/ASHRAE/ASHE addendum to ANSI/ASHRAE/ASHE Standard 170–2008, 2008. Oberg T, Brosseau LM (2008) Surgical mask filter and fit performance. AJIC 36(4):276–282 Kunachak S, Sobhon P (1998) The potential alveolar hazard of carbon dioxide laser-induced smoke. J Med Assoc Thail 81(4):278–282 Ball K (2001) Update for nurse anesthetists. Part I. The hazards of surgical smoke. AANA J 69(2):125–132 Brown, K.A., Esper, P., Kelleher, L.O., O’Neill, J.E.B., Polovich, M., & White, J.M. (Ed). (2001). Chemotherapy and biotherapy guidelines and recommendations for practice. Pittsburgh: Oncology Nursing Society. Connor TH (1993) An evaluation of the permeability of disposable polypropylene-based protective gowns to a battery of cancer chemotherapy drugs. Appl Occup Environ Hyg 8:785–789 Connor TH (1999) Permeability of nitrile rubber, latex, polyurethane, and neoprene gloves to 18 antineoplastic drugs. Am J Health Syst Pharm 56:2450–2453 Cass Y (1992) Musgrave CF Guidelines for the safe handling of excreta contaminated by cytotoxic agents. Am J Hosp Pharm 49(8):1957–1958 American Society of Hospital Pharmacists (1990) ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs. Am J Hosp Pharm 47:1033–1049 OSHA Technical Manual (OTM) | Section VI: Chapter 2 - Controlling Occupational Exposure To Hazardous Drugs. https://www.osha.gov/dts/osta/otm/otm_vi/otm_vi_2.html National Study Commission on Cytotoxic Exposure (1983) Recommendations for Handling Cytotoxic Agents. Louis P. Jeffrey, Sc.D., Chairman, Rhode Island Hospital, Providence, Rhode Island